UVIX VS Trust

CBOE Commodity Contracts Brokers & Dealers DE CIK: 0001793497
AI RATING
STRONG_SELL
97% Confidence

Investment Thesis

VS Trust exhibits catastrophic fundamental deterioration with a $623.5M net loss and -2354% YoY decline, coupled with severe negative operating cash flow of -$542.1M that renders the company insolvent on an operational basis. Despite a fortress balance sheet with minimal debt ($7.7M liabilities) and $124.8M cash, the unsustainable burn rate will deplete reserves within months while equity value is being rapidly destroyed at -114.8% ROE.

Strengths

  • + Zero leverage with debt-to-equity of 0.00x and minimal liabilities of $7.7M
  • + Strong balance sheet with $551.0M total assets and $543.3M stockholders' equity
  • + Substantial cash position of $124.8M provides temporary liquidity cushion

Risks

  • ! Catastrophic net loss of $623.5M with -2354% YoY deterioration indicating accelerating distress
  • ! Severe negative operating cash flow of -$542.1M annually indicating core business model failure
  • ! Missing revenue data and negative operating income (-$54.6K) suggest fundamental operational breakdown
  • ! Negative ROE (-114.8%) and ROA (-113.2%) show complete destruction of shareholder and asset returns
  • ! Cash burn rate of $542.1M annually depletes $124.8M reserves in approximately 2.7 months
  • ! No insider activity (zero Form 4 filings in 90 days) indicates lack of confidence from management

Key Metrics to Watch

Financial Metrics

Revenue
N/A
Net Income
-623.5M
EPS (Diluted)
$0.00
Free Cash Flow
-542.1M
Total Assets
551.0M
Cash
124.8M

Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE -114.8%
ROA -113.2%
FCF Margin N/A

Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
0.00x
Debt/Assets
1.4%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-18T10:39:21.693072 | Data as of: 2025-12-31 | Powered by Claude AI